---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-050785"
form_type: "8-K"
ticker: "SRTA"
cik: "0001779128"
company_name: "Strata Critical Medical, Inc."
filed_at: "2025-11-10T23:59:59+00:00"
generated_at: "2026-05-16T22:31:30.720619+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Strata Critical Medical Q3 revenue up 36.7% to $49.3M; net loss widens to $9.7M

## Summary
- Revenue $49.3M, up 36.7% YoY; organic growth 29.0% excluding Keystone acquisition.
- Net loss from continuing ops $(9.7)M, widened from $(5.6)M in prior-year period.
- Medical Segment Adjusted EBITDA $7.6M, +93.5% YoY; margin 15.3% (up 450 bps).
- Raised FY2025 revenue guidance to $185-195M; reaffirmed Adjusted EBITDA range.
- Investor Day on Nov 17, 2025 to introduce FY2026 guidance and medium-term targets.

## SEC filing metadata
- accession: 0001628280-25-050785
- form_type: 8-K
- ticker: SRTA
- cik: 0001779128
- company_name: Strata Critical Medical, Inc.
- filed_at: 2025-11-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1779128/000162828025050785/0001628280-25-050785-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1779128/000162828025050785/srta-20251110.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-050785
- JSON: https://secwatch.observer/filing/0001628280-25-050785.json
- Plain text: https://secwatch.observer/filing/0001628280-25-050785.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.